Seeing Is Believing
Currently out of the existing stock ratings of Tao Qiu, 35 are a BUY (77.78%), 10 are a HOLD (22.22%).
Analyst Tao Qiu, carries an average stock price target met ratio of 77.64% that have a potential upside of 25.79% achieved within 212 days. Previously, Tao Qiu worked at MACQUARIE, STIFEL, BERENBERG.
Tao Qiu’s has documented 90 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on HCSG, Healthcare Services Group at 29-Jul-2025.
Analyst best performing recommendations are on SGRY (SURGERY PARTNERS).
The best stock recommendation documented was for SGRY (SURGERY PARTNERS) at 11/29/2021. The price target of $51 was fulfilled within 9 days with a profit of $5.52 (12.14%) receiving and performance score of 13.49.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Mar-2022
$134
$17.94 (15.46%)
$139
Sell Since 19-Aug-2025
$96
$-20.06 (-17.28%)
$92
Buy Since 16-Dec-2024
$142
$45.05 (46.47%)
$150
Buy Since 22-Oct-2019
$135
$38.05 (39.25%)
$142
Buy Since 26-Feb-2025
$140
$43.05 (44.40%)
$142
What Year was the first public recommendation made by Tao Qiu?